Western blot analysis confirmed the increase of IGF1 and decrease of IGF1R in the PCOS group vs. the Ctrl group, respectively, and the improvement in response to RES treatment (Figures 1F–H). This evidence concerns the gene IGF1R and polycystic ovary syndrome.